Head-to-head · WeighScore
Heally vs Nucific
The verdict
Heally takes it — 70.9/100 to 56.2/100.
Heally grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Heally is a US telehealth platform connecting patients with licensed providers for GLP-1 weight loss prescriptions; care is by HLY Medical Group PA.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Heally | Nucific |
|---|---|---|
| WeighScore | 70.9/100 | 56.2/100 |
| Grade | C | C |
| Scorecard rank | #102 | #418 |
| Semaglutide | $199/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $299/mo (starting dose, brand-name) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #102 · C
Strengths
- Broad GLP-1 menu: semaglutide, tirzepatide and liraglutide (branded or compounded)
- LegitScript verified; care provided by HLY Medical Group PA
- Semaglutide from ~$199/mo with a $100-off first-month promotion
- Medications ship from licensed, state-regulated pharmacies with free shipping
- Available in almost every state (excluding Alaska and DC)
Where it loses points
- Compounded medications are not FDA-evaluated for safety, efficacy or quality
- Cash-pay; FSA/HSA acceptance not stated on the platform
- Some pricing routes through LillyDirect rather than Heally directly
- Specific list of supported states not consolidated for easy review
Graded #418 · C
Strengths
- Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
- Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
- Discloses that featured patients were compensated for their time
- Labels its NAD+ decline chart as illustrative and not a measurement, with an unusually careful methodology note
- Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalogue
Where it loses points
- No price is published anywhere; every option is gated behind a three-minute quiz
- The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so the certification could not be verified
- A BBB Accredited A+ claim is displayed without a link to the BBB profile
- No state list and no named pharmacy, only licensed U.S. pharmacies
- Before-and-after photographs are used alongside compensated testimonials
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.